Hexarelin
Symbol Hx · MW 887 Da
Potent GH secretagogue with cardioprotective signaling.
- Discovered
- 1992
- Half-life
- 60 minutes
- Approval
- Not FDA-approved
Quick facts
- Category
- Hormone
- Route
- Injectable
- Molecular weight
- 887 Da
- Half-life
- 60 minutes
- Discovered
- 1992
- Approval status
- Not FDA-approved
Reported effects
- High GH release
- Cardioprotection
- Recovery
Overview
Hexarelin is a powerful synthetic growth hormone secretagogue that stimulates the release of growth hormone from the pituitary gland. It is often considered more potent than several other GH-releasing peptides. Hexarelin is commonly researched for hormone support, recovery, lean mass maintenance, and physical performance-related recovery. Because of its strength, it may have a higher potential to affect other hormone pathways and may require more caution than milder peptides. Its main purpose is strong growth hormone stimulation through the body's natural endocrine signaling system.
Evidence context
Hexarelin evidence summary
Human clinical evidence
Hexarelin has an approval context listed in the Peptidic database. Approved use still depends on the specific indication, formulation, labeling, and clinician guidance.
Animal, preclinical, or formulation evidence
Hexarelin may be discussed in animal, preclinical, in vitro, or early-stage research contexts. Those evidence types are useful for orientation but should not be treated as equivalent to approved human indications.
Status and evidence strength
Peptidic lists the approval status for Hexarelin as Not FDA-approved. The reported effects below are reference fields from the peptide database, not medical promises. Source links are included later on the page when available so readers can continue review from primary or reputable sources.
How it's taken
- Typical Administration
- Injectable
- Typical Dosage
- No established approved dosage; commonly referenced range is 100–200 mcg per injection
- Typical Frequency
- 1–2 times daily
Dosing depends on the approved indication, formulation, titration schedule, and clinician guidance. This page is educational and not a substitute for medical advice.
Research sources
Source links included from peer-reviewed literature, clinical records, and medical databases for educational research context on Hexarelin.
Internal links
Related peptides
Frequently asked questions
What category is Hexarelin in?
Hexarelin is listed in the Hormone category on Peptidic.
What route is Hexarelin associated with?
Hexarelin is associated with the injectable route in the Peptidic database. This is descriptive route context, not a use instruction.
Is Hexarelin approved?
Peptidic lists the approval status for Hexarelin as: Not FDA-approved. Approval details can vary by indication and jurisdiction.
Interested in Hexarelin?
Enter your email and we'll send our recommended peptide vendor for educational research reference.
Review the peptide vendor research checklistEducational reference only · No spam · Unsubscribe anytime
For educational purposes only. Many peptides shown are research compounds and not approved for human use in all jurisdictions. Explore the full peptide database, peptide calculator, or peptide tracker.
Last reviewed for educational accuracy: 2026-06-01